» Articles » PMID: 38808117

Different Roles of Circulating and Intramuscular GDF15 As Markers of Skeletal Muscle Health

Overview
Specialty Endocrinology
Date 2024 May 29
PMID 38808117
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Growth Differentiation Factor 15 (GDF15) is a mitokine expressed in response to various stresses whose circulating levels increase with age and are associated with numerous pathological conditions, including muscle wasting and sarcopenia. However, the use of circulating GDF15 (c-GDF15) as a biomarker of sarcopenia is still debated. Moreover, the role of GDF15 intracellular precursor, pro-GDF15, in human skeletal muscle (SM-GDF15) is not totally understood. In order to clarify these points, the association of both forms of GDF15 with parameters of muscle strength, body composition, metabolism and inflammation was investigated.

Methods: the levels of c-GDF15 and SM-GDF15 were evaluated in plasma and muscle biopsies, respectively, of healthy subjects (HS) and patients with lower limb mobility impairment (LLMI), either young (<40 years-old) or old (>70 years-old). Other parameters included in the analysis were Isometric Quadriceps Strength (IQS), BMI, lean and fat mass percentage, thickness, as well as circulating levels of Adiponectin, Leptin, Resistin, IGF-1, Insulin, IL6, IL15 and c-PLIN2. Principal Component Analysis (PCA), Canonical Discriminant Analysis (CDA) and Receiving Operating Characteristics (ROC) analysis were performed.

Results: c-GDF15 but not SM-GDF15 levels resulted associated with decreased IQS and IGF-1 levels in both HS and LLMI, while only in LLMI associated with increased levels of Resistin. Moreover, in LLMI both c-GDF15 and SM-GDF15 levels were associated with IL-6 levels, but interestingly SM-GDF15 is lower in LLMI with respect to HS. Furthermore, a discrimination of the four groups of subjects based on these parameters was possible with PCA and CDA. In particular HS, LLMI over 70 years or under 40 years of age were discriminated based on SM-GDF15, c-GDF15 and Insulin levels, respectively.

Conclusion: our data support the idea that c-GDF15 level could be used as a biomarker of decreased muscle mass and strength. Moreover, it is suggested that c-GDF15 has a different diagnostic significance with respect to SM-GDF15, which is likely linked to a healthy and active state.

Citing Articles

Impact of physical activity on physical function, mitochondrial energetics, ROS production, and Ca handling across the adult lifespan in men.

Cefis M, Marcangeli V, Hammad R, Granet J, Leduc-Gaudet J, Gaudreau P Cell Rep Med. 2025; 6(2):101968.

PMID: 39933528 PMC: 11866497. DOI: 10.1016/j.xcrm.2025.101968.


Health implications of racial differences in serum growth differentiation factor levels among men with obesity.

Bathina S, Fuenmayor Lopez V, Prado M, Ballato E, Colleluori G, Tetlay M Physiol Rep. 2024; 12(23):e70124.

PMID: 39668628 PMC: 11638490. DOI: 10.14814/phy2.70124.

References
1.
Conte M, Martucci M, Sandri M, Franceschi C, Salvioli S . The Dual Role of the Pervasive "Fattish" Tissue Remodeling With Age. Front Endocrinol (Lausanne). 2019; 10:114. PMC: 6400104. DOI: 10.3389/fendo.2019.00114. View

2.
Bian A, Hu H, Rong Y, Wang J, Wang J, Zhou X . A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α. Eur J Med Res. 2017; 22(1):25. PMC: 5508730. DOI: 10.1186/s40001-017-0266-9. View

3.
Conte M, Santoro A, Collura S, Martucci M, Battista G, Bazzocchi A . Circulating perilipin 2 levels are associated with fat mass, inflammatory and metabolic markers and are higher in women than men. Aging (Albany NY). 2021; 13(6):7931-7942. PMC: 8034884. DOI: 10.18632/aging.202840. View

4.
Rosenberg B, Hirano M, Quinzii C, Colantuoni E, Needham D, Lederer D . Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure. Thorax. 2019; 74(11):1099-1101. PMC: 7043788. DOI: 10.1136/thoraxjnl-2019-213621. View

5.
Wang T . Searching for the link between inflammaging and sarcopenia. Ageing Res Rev. 2022; 77:101611. DOI: 10.1016/j.arr.2022.101611. View